메뉴 건너뛰기




Volumn 84, Issue 2, 2013, Pages 202-208

Pharmaceutical prescription for multiple sclerosis: Evaluation of pharmaceutical consumption at private health insurance;Myofibrilläre Myopathie bei ZASP-Mutation Ala147Thr: Zwei Fälle mit rein distalem Phänotyp der Beine

Author keywords

Multiple sclerosis; Pharmaceutical consumption; Pharmaceutical prescription; Private health insurance; Statutory health insurance

Indexed keywords

ARTICLE; FEMALE; GERMANY; HUMAN; MALE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIVATE HEALTH INSURANCE; ADOLESCENT; ADULT; AGE; AGED; CHILD; CLINICAL PRACTICE; DRUG UTILIZATION; HEALTH INSURANCE; MIDDLE AGED; PUBLIC HEALTH; SEX DIFFERENCE; STATISTICS; UTILIZATION REVIEW; VERY ELDERLY;

EID: 84879884074     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-012-3683-6     Document Type: Article
Times cited : (4)

References (26)
  • 2
    • 77956706293 scopus 로고    scopus 로고
    • Arzneimittelverordnungen nach Alter und Geschlecht
    • Schwabe U, Paffrath D (Hrsg) Springer, Heidelberg
    • Coca V, Nink K (2011) Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungs-Report. Springer, Heidelberg, S 944
    • (2011) Arzneiverordnungs-Report , pp. 944
    • Coca, V.1    Nink, K.2
  • 5
    • 0037154192 scopus 로고    scopus 로고
    • Disease modifying therapies in multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American academy of neurology and the MS council for clinical practice guidelines
    • Goodin D et al (2002) Disease modifying therapies in multiple sclerosis - report of the therapeutics and technology assessment subcommittee of the American academy of neurology and the MS council for clinical practice guidelines. Neurology 58:169-178 (Pubitemid 34086933)
    • (2002) Neurology , vol.58 , Issue.2 , pp. 169-178
    • Goodin, D.S.1    Frohman, E.M.2    Garmany Jr., G.P.3    Halper, J.4    Likosky, W.H.5    Lublin, F.D.6    Silberberg, D.H.7    Stuart, W.H.8    Van Den Noort, S.9
  • 7
    • 17644441679 scopus 로고    scopus 로고
    • Hochrechnung der zahl an multiple sklerose erkrankten patienten in Deutschland
    • DOI 10.1007/s001150050559
    • Hein T, Hopfenmüller W (2000) Hochrechnung der Zahl der an Multiple Sklerose erkrankten Patienten in Deutschland. Nervenarzt 71:288-294 (Pubitemid 30210324)
    • (2000) Nervenarzt , vol.71 , Issue.4 , pp. 288-294
    • Hein, T.1    Hopfenmuller, W.2
  • 8
    • 4344675269 scopus 로고    scopus 로고
    • Symptomatische Therapie der Multiplen Sklerose
    • Henze T et al (2004) Symptomatische Therapie der Multiplen Sklerose. Nervenarzt 75(Suppl 1):2-39
    • (2004) Nervenarzt , vol.75 , Issue.SUPPL. 1 , pp. 2-39
    • Henze, T.1
  • 9
    • 78751640452 scopus 로고    scopus 로고
    • Analysis of current multiple sclerosis register
    • Hurwitz BJ (2011) Analysis of current multiple sclerosis register. Neurology 76(1 Suppl 1):7-13
    • (2011) Neurology , vol.76 , Issue.1 SUPPL. 1 , pp. 7-13
    • Hurwitz, B.J.1
  • 12
    • 79951605437 scopus 로고    scopus 로고
    • Sun exposure and vitamin D are independent risk factors for CNS demyelination
    • Lucas RM et al (2011) Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 76:540-548
    • (2011) Neurology , vol.76 , pp. 540-548
    • Lucas, R.M.1
  • 13
    • 84882513785 scopus 로고    scopus 로고
    • Compston A et al (Hrsg) McAlpine's multiple sclerosis. Aufl. Churchill Livingstone, Edinburgh
    • McDonald I, Compston A (2006) The symptoms and signs of multiple sclerosis. In: Compston A et al (Hrsg) McAlpine's multiple sclerosis. Aufl. Churchill Livingstone, Edinburgh
    • (2006) The Symptoms and Signs of Multiple Sclerosis
    • McDonald, I.1    Compston, A.2
  • 14
    • 84879881455 scopus 로고    scopus 로고
    • MSTKG Leitlinie der Multiple Sklerose Konsensusgruppe (MSTKG)
    • MSTKG (2004) Diagnostik und Therapie der Multiplen Sklerose, Leitlinie der Multiple Sklerose Konsensusgruppe (MSTKG)
    • (2004) Diagnostik und Therapie der Multiplen Sklerose
  • 16
    • 0002558415 scopus 로고
    • The changing diagnostic pattern of multiple sclerosis in an epidemiological area
    • Poser S, Bauersfeld T (1995) The changing diagnostic pattern of multiple sclerosis in an epidemiological area. J Neuroimmunol (Suppl 1):72
    • (1995) J Neuroimmunol , vol.72 , Issue.SUPPL. 1
    • Poser, S.1    Bauersfeld, T.2
  • 18
    • 84879882424 scopus 로고    scopus 로고
    • TLR7-driven accumulation of a novel CD11c+ B-cell population is impor-tant for the development of autoimmunity
    • Rubtsov A et al (2011) TLR7-driven accumulation of a novel CD11c+ B-cell population is impor-tant for the development of autoimmunity. Blood 118:1187-1188
    • (2011) Blood , vol.118 , pp. 1187-1188
    • Rubtsov, A.1
  • 19
  • 21
    • 73449089131 scopus 로고    scopus 로고
    • Symptomatology of MS: Results from the german ms registry
    • Stuke et al (2009) Symptomatology of MS: results from the German MS Registry. J Neurol 256:1932-1935
    • (2009) J Neurol , vol.256 , pp. 1932-1935
    • Stuke1
  • 22
    • 84858705516 scopus 로고    scopus 로고
    • The cost of multiple sclerosis in Norway
    • Svendsen B et al (2012) The cost of multiple sclerosis in Norway. Eur J Health Econ 13:81-91
    • (2012) Eur J Health Econ , vol.13 , pp. 81-91
    • Svendsen, B.1
  • 23
    • 2642659408 scopus 로고    scopus 로고
    • Burden of illness of multiple sclerosis Part 1: Cost of illness
    • The Canadian Burden of Illness Study Group
    • The Canadian Burden of Illness Study Group (1998) Burden of illness of multiple sclerosis. Part 1: cost of illness. Can J Neurol Sci 25:23-30
    • (1998) Can J Neurol Sci , vol.25 , pp. 23-30
  • 24
    • 0031796527 scopus 로고    scopus 로고
    • The natural history of multiple sclerosis: Update 1998
    • Weinshenker B (1998) The natural history of multiple sclerosis: update 1998. Semin Neurol 18:301-307 (Pubitemid 28488946)
    • (1998) Seminars in Neurology , vol.18 , Issue.3 , pp. 301-307
    • Weinshenker, B.G.1
  • 26
    • 84879889374 scopus 로고    scopus 로고
    • Immuntherapeutika und Zytostatika
    • Schwabe U, Paffrath D (Hrsg Springer, Heidelberg
    • Zeller WJ (2011) Immuntherapeutika und Zytostatika. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungs-Report. Springer, Heidelberg, S 944
    • (2011) Arzneiverordnungs-Report , vol.944
    • Zeller, W.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.